Meta-analysis of the performance of (18)F-FDG PET in cutaneous melanoma. - Wikidata - wikimedia - TriplyDB

Meta-analysis of the performance of (18)F-FDG PET in cutaneous melanoma.

Meta-analysis of the performance of (18)F-FDG PET in cutaneous melanoma.

http://www.wikidata.org/entity/Q37591301

about

F-18-fluoro-2-deoxyglucose positron emission tomography (PET) and PET/computed tomography imaging in primary staging of patients with malignant melanoma: a systematic review Surgery of primary melanomas.Metabolic positron emission tomography imaging in cancer detection and therapy response.FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0.PET-CT in the sub-arctic region of Norway 2010-2013. At the edge of what is possible?Quantified ultrasound elastography in the assessment of cutaneous carcinoma Clinical impact of (18)F-FDG PET-CT in recurrent stage III/IV melanoma: a tertiary centre Specialist Skin Cancer Multidisciplinary Team (SSMDT) experience.Primary pulmonary melanoma: the unexpected tumour The Development of a Checklist to Enhance Methodological Quality in Intervention Programs.No benefit in staging fluorodeoxyglucose-positron emission tomography in clinically node-negative head and neck cutaneous melanoma.Current molecular imaging positron emitting radiotracers in oncology.The role of FDG-PET/CT in preoperative staging of sentinel lymph node biopsy-positive melanoma patients.Early detection and longitudinal monitoring of experimental primary and disseminated melanoma using [¹⁰F]ICF01006, a highly promising melanoma PET tracer.Bone radionuclide therapy and increased survival with radium-223 is the way to go for nuclear medicine: the offer that oncologists cannot refuse.Feature analysis of ultrasound elastography image for quantitative assessment of cutaneous carcinoma.Evaluation of 18F-FDG PET/CT Parameters for Detection of Lymph Node Metastasis in Cutaneous Melanoma.PET Scan Misses Cutaneous Melanoma Metastasis with Significant Tumour Size and Tumour Thickness.Cost-effectiveness analysis of staging strategies in patients with regionally metastatic melanoma.PET/CT in malignant melanoma: contrast-enhanced CT versus plain low-dose CT.[Whole-body staging of malignant melanoma: advantages, limitations and current importance of PET-CT, whole-body MRI and PET-MRI].Malignant melanoma

P2860

Q26830033-09BC60E2-D2B1-4108-9791-3DAC78A0A792 Q30356095-B830161B-FFE9-4C6A-86C3-507B09F29F4D Q34786518-5B2891CA-1CEC-4165-8C08-C2DDE3A23C7E Q35043725-F59F86A3-A29E-4604-A453-8D16C0498564 Q35758278-72D42415-849E-4B5F-8904-7A36560D38CA Q36514503-E99DAE23-27CF-41BD-9781-E2F9D83278AF Q37192805-A4F51A26-66A7-4E28-9634-7EC8F95B1007 Q37292866-4A93EE57-E72C-46DD-8CC1-483D049CF94E Q37421215-F725D048-6B21-42BD-BE78-0DE28B63DAE4 Q38129831-9988C312-492E-4370-B4E7-B34CF2BD2D25 Q38217835-F0366948-15A2-450F-BD84-D3866ED01434 Q39317681-F51830AE-080B-42E4-959F-B45F3FD7D599 Q43480586-A3F85A61-7A35-45D4-B5AC-764897827801 Q48043072-3BA08087-8CDF-4762-803F-97834B95999C Q48132208-8F159B18-3EBE-42CE-88BC-95C4E62CB600 Q49386803-2E8F867A-E9F6-4947-83C3-BE93F1973F32 Q49837639-1BE647F0-6D48-4326-93F6-4DEDB9AE7BDC Q51032948-2E46A09B-766D-4E16-8B95-47AFAA8AE857 Q53251672-5F253C36-82B1-4E5D-A8CB-E26EA29BDD6F Q53637858-E2322EBD-0D29-4F14-8652-E20882A72760 Q58690762-E9AD2E7C-729E-4465-B769-5BD68A019B3D

P2860

Meta-analysis of the performance of (18)F-FDG PET in cutaneous melanoma.

http://www.wikidata.org/entity/Q37591301

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 02 September 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Meta-analysis of the performance of (18)F-FDG PET in cutaneous melanoma.

@en

Meta-analysis of the performance of

@nl

type

label

Meta-analysis of the performance of (18)F-FDG PET in cutaneous melanoma.

@en

Meta-analysis of the performance of

@nl

prefLabel

Meta-analysis of the performance of (18)F-FDG PET in cutaneous melanoma.

@en

Meta-analysis of the performance of

@nl

P1433

Q37591301-23872A92-C5D2-4ED7-89CD-C57AC79298E5

P1476

Q37591301-4921BECA-F7F7-4D3B-B7B2-AFB56F6F9038

P2093

Q37591301-3D066B63-1B1E-4141-982B-FD4A48C6015B

Q37591301-6630207F-7715-4B52-9BA4-5C465E750534

Q37591301-CE7904F9-7D9D-4314-B793-DF7D072DF57B

Q37591301-D6747496-65FE-4525-B68A-5F1ED764402C

Q37591301-E5AE84A3-1EC8-41DA-80BD-EFC9A4BFDC44

Q37591301-E995CEEB-4DDE-4E54-B381-47C5D916E7CD

Q37591301-F70AC3A5-899B-448A-B893-B6E0DE6E8D2E

P2860

Q37591301-026B88FC-39D4-493F-B47A-4BE5F3FF189E

Q37591301-3F2FC272-7682-43C6-9D38-709FD4BE40BD

Q37591301-42984CCA-0250-4897-A613-C4A34D67BD5E

Q37591301-484621FD-8580-4C8E-A1DD-A9636741A158

Q37591301-48A1B6CD-5AE4-4B20-B777-415FB48ADDB9

Q37591301-4CB27068-649B-4006-B3AB-A1E4B0E4E861

Q37591301-53580B76-D069-4AB7-B7E5-9B59177DCDDE

Q37591301-871ECAD0-1132-4414-A981-1CE7751346C1

Q37591301-A621204C-7322-4AAA-84BD-DB1CC3F51BBD

Q37591301-DCD7FC17-FC97-4440-8FD6-B42D453EFFA5

P2888

Q37591301-8006C28F-C3C6-4E10-B8C4-E67036CD063C

P304

Q37591301-07E5CE4B-F7C9-41F8-ABD2-8C1B66E7C918

P31

Q37591301-65124b71-0046-489c-8160-d51edacfd7f8

Q37591301-C28EBEDB-559A-456B-AAA4-E6A57E8A5330

P356

Q37591301-532CF0E8-29B3-4496-B05B-34A97125E2F0

P433

Q37591301-F47EE236-AD76-4B97-9DE9-EE7EA61CFD60

P478

Q37591301-F04AFAF5-47B3-4A91-8682-7511122F7D60

P577

Q37591301-F304B4CC-5456-4FB6-910F-54BF26C53F38

P5875

Q37591301-AFA845E5-11B2-4AE3-93C8-9481F09908E5

P698

Q37591301-EBC89B48-B7DF-4C41-9B6F-763E954B755E

P921

Q37591301-7C014C75-06B0-49AA-8EBD-632894C43BCC

P932

Q37591301-CBE41ABF-45E6-4030-934B-AC1EC6F2F74D

P356

S00259-009-1224-8

P1433

European Journal of Nuclear Medicine and Molecular Imaging

P1476

Meta-analysis of the performance of (18)F-FDG PET in cutaneous melanoma.

@en

P2093

Cristina Fernández-Pérez

http://www.w3.org/2001/XMLSchema#string

Felisa Jiménez-Requena

http://www.w3.org/2001/XMLSchema#string

José L Carreras-Delgado

http://www.w3.org/2001/XMLSchema#string

José M Pérez-Vázquez

http://www.w3.org/2001/XMLSchema#string

Judy Schwimmer

http://www.w3.org/2001/XMLSchema#string

Roberto C Delgado-Bolton

http://www.w3.org/2001/XMLSchema#string

Sanjiv S Gambhir

http://www.w3.org/2001/XMLSchema#string

P2860

The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews

Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis.

Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies.

Combined FDG-PET/CT for the detection of unknown primary tumors: systematic review and meta-analysis.

A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer.

A review of the literature for whole-body FDG PET in the management of patients with melanoma.

Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations.

Malignant melanoma: staging with whole-body positron emission tomography and 2-[F-18]-fluoro-2-deoxy-D-glucose.

Full publication of results initially presented in abstracts. A meta-analysis.

Formulating questions and locating primary studies for inclusion in systematic reviews.

P2888

s00259-009-1224-8

P304

284-300

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00259-009-1224-8

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P577

2009-09-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26786985

http://www.w3.org/2001/XMLSchema#string

P698

19727717

http://www.w3.org/2001/XMLSchema#string

P921

P932

2886141

http://www.w3.org/2001/XMLSchema#string